Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.090
-0.020 (-0.64%)
Aug 31, 2026, 11:28 AM EDT - Market open
Altimmune Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Altimmune stock has a consensus rating of "Strong Buy" and an average price target of $17.22. The average 1-year stock price forecast is 457.28% higher than the current stock price, while the lowest is $11 (+255.99%) and the highest is $28 (+806.15%).
Price Target: $17.22 (+457.28%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Altimmune stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 7 | 7 | 7 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 1 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 10 | 11 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +547.25% | Aug 17, 2026 |
| Barclays | Barclays | Buy Maintains $20 | Buy | Maintains | $20 | +547.25% | Aug 13, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $28 | Buy | Maintains | $28 | +806.15% | Aug 13, 2026 |
| William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 12, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 29, 2026 |
Financial Forecast
Revenue This Year
n/a
from 41.00K
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-0.59
from -1.00
EPS Next Year
-0.67
from -0.59
EPS and Forward PE are based on non-GAAP adjusted numbers.